Statistics
Total Visits
| Views | |
|---|---|
| A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group Study | 161 |
Total Visits Per Month
| March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | |
|---|---|---|---|---|---|---|---|
| A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group Study | 0 | 2 | 3 | 6 | 1 | 8 | 6 |
Top country views
| Views | |
|---|---|
| United States | 68 |
| Poland | 64 |
| Ireland | 12 |
| China | 5 |
| Japan | 3 |
| India | 2 |
| Slovenia | 2 |
| Argentina | 1 |
| Belgium | 1 |
| France | 1 |
Top cities views
| Views | |
|---|---|
| Warsaw | 64 |
| Dublin | 12 |
| Louisville | 11 |
| San Ramon | 8 |
| Ashburn | 6 |
| Boardman | 6 |
| Des Moines | 6 |
| Fairfield | 5 |
| Beijing | 4 |
| Ann Arbor | 3 |